The biologics market is made up of companies that manufacture biological commodities derived from human DNA and genetically engineered proteins. Biologic goods include recombinant therapeutic proteins, gene therapy tissues, somatic cells, vaccines, and allergenic substances. Due to the growing prevalence of chronic diseases and rising demand for biologics globally, the market for biologics is expected to grow. Cancers include breast cancer, lung cancer, bladder cancer, prostate cancer, colorectal cancer, and skin cancer are all treated using biologics. Therefore, it is anticipated that an increase in the prevalence of different cancers will spur demand for biologics products and, as a result, market expansion. Additionally, expanding clinical investigations as well as rising demand and acceptance for novel therapies are projected to fuel market growth.
The projection period (2023-2030) will see a CAGR of 9.3% in the global Biologics Market.
Top Companies in the Biologics Industry:
1. Novartis AG
Novartis AG was founded in 1996 as a result of the combination of Sandoz and Ciba-Geigy. The headquarters of Novartis were located in Basel, Switzerland. It makes life better and longer. Around 140 nations have partners with Novartis AG. Novartis stated in September 2022 that it would invest in next-generation biotherapeutics by establishing a fully integrated, dedicated USD 300 million scientific environment to strengthen its capacity and capabilities for early technical development of biologics.
2. AstraZeneca PLC
AstraZeneca PLC is a multinational pharmaceutical and biotechnology firm that is British and Swedish. With its headquarters in England, the UK, it was established in 1999. It works in more than 100 nations.. In December 2021, AstraZeneca started working on the subsequent generation of drug delivery systems. Using a balanced strategy of internally produced technology and external collaborations, the company is striving to develop medications and delivery agents that can reach difficult-to-reach intracellular targets. It focuses on lipid nanoparticles (LNPs) as a potential and distinctive delivery system for nucleotide-based treatments that induce the creation of proteins in cells. The most cutting-edge method for mRNA delivery, LNPs have a track record for delivering nucleic acids. LNPs can transport mRNA into cells after intravenous, subcutaneous, or pulmonary infusion and trigger the production of cellular proteins. The company is currently focusing on enhancing the efficacy and safety profile of the medicine delivery system.
3. Bayer AG
Bayer AG is a German multinational pharmaceutical and biotechnology firm that was formed in 1863 and is one of the world's largest pharmaceutical corporations. The company's headquarters are in Leverkusen, Germany. Bayer has 83 offices worldwide, including Canada, Mexico, Germany, and Switzerland. In order to develop biological solutions in areas including nitrogen optimization, carbon sequestration, and next-generation crop protection/Open Innovation, Ginkgo Bioworks will join Bayer as a multi-year strategic partner in October 2022. By utilizing the global open innovation ecosystem, sourcing aims to accelerate the R&D process for biological products. Bayer will keep working to improve Joyn Bio's nitrogen fixation technology in order to eventually replace synthetic fertilizers.
4. Sanofi SA
Sanofi SA is a multinational pharmaceutical and healthcare firm based in France. It was established in 1973 and has its headquarters in Paris, France. It is present in about 40 low and lower-middle income nations.
5. Pfizer Inc
Pfizer Inc is an 1849-founded, international American pharmaceutical and biotechnology firm. The headquarters are in New York's Williamsburg. It works in more than 181 nations. In May 2019, the company announced the inauguration of a new 175,000-square-foot production plant in Andover, Massachusetts. Commercial manufacturing and product development services are housed at Pfizer's Andover location, with colleagues dedicated to the development and production of high-quality complex biologics and vaccines.
6. Merck & Co
Merck & Co is an American international pharmaceutical firm that was formed in 1668 and is headquartered in New Jersey, United States. It is present in 66 countries. To accommodate the demand for its medications and vaccines, Merck & Co. started building a new facility at its Carlow, Ireland location in August 2022. Merck & Co. (also known as MSD outside of North America) has announced plans to build a new facility at its current location in Carlow, Ireland, which is roughly 80 kilometers south-west of Dublin. This new facility will be dedicated solely to the production of next-generation oncology biologics.
7. GlaxoSmithKline PLC
GlaxoSmithKline PLC is a British multinational pharmaceutical and biotechnology company. It was founded in 2000 and headquartered in England, UK. It operates across the world. In June 2021, New GSK will offer a step-change in growth and performance over the following ten years, fueled by a portfolio of high-quality Vaccines and Specialty Medicines, as well as a late-stage pipeline.
8. Amgen Inc
Amgen Inc is an American multinational biopharmaceutical company founded in 1980 and is headquartered in California, United States. It operates in 100 countries and has global presence.
9. F. Hoffmann-La Roche AG
F. Hoffmann-La Roche AG established in 1896, which is frequently referred to as Roche, is a worldwide healthcare organization. Basel, Switzerland serves as the location of the corporate headquarters. It is operating in more than 130 nations.
10. Eli Lilly and Company
Eli Lilly and Company is an American pharmaceutical company, was founded in 1876 and headquartered in Indianapolis, Indiana. It operates in 18 countries. Eli Lilly ups its investment in its brand-new biologics manufacturing facility in March 2023.
*Definition: Biologicals are a diverse group of medicines which includes vaccines, growth factors, immune modulators, monoclonal antibodies, as well as products derived from human blood and plasma.
